RS

Reena Singh

Active Director Director DIN 08346257
DIN 08346257 First appointment Jan 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Reena Singh

Data last updated:

Reena Singh is a Director at Globocare Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Globocare Pharmaceuticals Private Limited reported revenue of ₹44.3 Lakh (FY 2023).

DIN 08346257
Primary Designation Director
Industry Chemicals
First Appointment 30 Jan 2019
Oldest Company Age 14 yrs
Largest company Globocare Pharmaceuticals Private Limited · ₹44.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20192012₹44.3 Lakh (FY 2023)Active

Board colleagues of Reena Singh

NameDINCompanyDesignation
Nibha Rani05258848Globocare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globocare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reena Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Singh

Reena Singh currently holds 1 directorship: Globocare Pharmaceuticals Private Limited (Director, since 30 Jan 2019, revenue ₹44.3 Lakh (FY 2023)).

Reena Singh was first appointed on 30 Jan 2019 as Director at Globocare Pharmaceuticals Private Limited.

The current boards of Reena Singh's companies include Nibha Rani (Globocare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available